Prof. Dr. re. pole. Uwe May
ist Volkswirt und Gesundheitsökonom. Als Studiendekan an der Hochschule Fresenius ist er für den Masterstudiengang International Pharmacoeconomics, Health Economics and Market Strategies for Healthcare Products (M.Sc.) verantwortlich. Er ist Mitbegründer der Unternehmensberatung May und Bauer – Konzepte im Gesundheitsmarkt. Seine Schwerpunkte sind Gesundheits- und Pharmakoökonomie sowie Kosten- und Nutzenbewertungen.
Articles
- Zeit für Eigenverantwortung
MVF 04/26
- Ensuring the supply of medicines through pharmaceutical wholesalers
Issue 01/2023
- Biosimilar market 2022: Is there an alternative to exclusive discount contracts?
Edition 04 / 2021
- Open house contracts and auxiliary tax discounts in the biosimilar market: Realistic savings volumes for the statutory health insurance
Issue 04/2020
- Drug discount contracts: cost reduction with risks and side effects
Issue 06/2019
- “A bet on the future of the German system”
Issue 04/2018
- More data for health services research
Issue 05/2013
- Reimbursability of nicotine replacement therapy within the framework of the statutory health insurance
Issue 01/2013
- Quality competition among health insurance companies
MVF 01/10
- Reimbursement price corridor model
MVF 06/09
- Smoking cessation with nicotine replacement therapy to reduce healthcare costs
MVF 04/09
- Cost-benefit-based determination of the appropriate reimbursement price for medicines in the statutory health insurance system
MVF 04/08
